My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Nike Q2 Earnings: Revenue Beat, EPS Beat, Sha...
FedEx Stock Rallies On Better-Than-Expected Q...
Disney Hits $2 Billion Domestic Box Office, E...
Amazon Shares Rise As Company Says Operations...
4 Micron Analysts Size Up Q1 Earnings: 'An Op...
Block Positioned For Margin Expansion And EPS...
Birkenstock's High-end Lifestyle Positioning...
Astronauts Sunita Williams, Butch Wilmore's...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ELI LILLY AND COMPANY (NYSE: LLY)

    Overview
    current price
    $767.76
    $767.76
    change
    10.22 | 1.35%
    10.22 | 1.35%
    Yesterday's Close
    757.54
    open
    811.35
    volume
    9.94 M
    30d. avg volume.
    4.11 M
    1 day
    766.61 - 811.35
    52 weeks
    567.02 - 972.53
    p/e
    83.00
    beta
    0.4088
    market cap
    728.85 B
    dividend yield
    0.78%
    Industry
    -
    LLY by TradingView
    News and Commentary
    Market Update: Dow Breaks Longest Losing Streak in 50 Years The Dow Jones Industrial Average broke its longest losing streak in 50 years on Thursday, closing slightly above the flatline, as market participants digested the Federal Reserve...
    Market Update: Nasdaq Soars Above 20,000 First Time The Nasdaq Composite closed above 20,000 for the first time ever as market participants expect the Federal Reserve to issue another interest rate cut next week following November...
    Eli Lilly Investments In Production Reach $23 Billion With Additional $3 Billion Expansion At US Fac... On Thursday, Eli Lilly And Co (
    Market Update: Stocks Little Changed Ahead of November Jobs Report Stocks were little changed Thursday following a record day for equities, as bullishness from the cryptocurrency market drove most gains early in the session. Stocks continued to...
    Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss? On Wednesday, Eli Lilly And Co (
    Market Update: Dow Jumps 300 Points, S&P 500, Nasdaq Climb to Record Highs Stocks rose Wednesday as strong earnings reports pulled the broader market higher. The Dow Jones Industrial Average climbed over 300 points -- closing above 45,000 for the first...
    Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study According to research published in JAMA Network Open, the use of anti-obesity medications, including glucagon-like peptide-1 receptor agonists, was associated with lower incidenc...
    Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs The Biden-Harris Administration has proposed expanding Medicare and Medicaid coverage for anti-obesity medications, aiming to address the high costs that have drawn criticism. In...
    Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip? Eli Lilly & Co. (LLY&nb...
    Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.
    StockTwits
    StockTwits
    Most Shared
    Nordstrom Q3 Sales Grow, But Analysts Remain Cautious On Stock Amid Slowing Sales And Elevated Inventory
    Warner Bros Discovery Stock Soars After Multi-Year Deal with Comcast; Comcast Shares Slide On Subscriber Loss Estimates
    Apple's iPhone 16 Stumbles On 'Intelligence' Awareness, But Pro Max Shines Bright: Analyst
    Most Popular
    Market Update: Dow, S&P 500 Climb in Best Month of 2024
    Consumer Confidence Hits 2-Year High As Recession Fears Fade: Stock Market Optimism Soars To Record High
    Nordstrom Q3 Sales Grow, But Analysts Remain Cautious On Stock Amid Slowing Sales And Elevated Inventory
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Google
    Covid19
    Tesla
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2024 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?